In healthcare, digital care and telemedicine efforts are mostly viewed as an add-on to US healthcare, but that mindset should be flipped, argued Sean Duffy, CEO of Omada Health, in a piece written for The New England Journal of Medicine, titled “In-Person Healthcare as Option B.”
In healthcare, digital care and telemedicine efforts are mostly viewed as an add-on to US healthcare, but that mindset should be flipped, argued Sean Duffy, CEO of Omada Health, in a piece written for The New England Journal of Medicine, titled “In-Person Healthcare as Option B.”
Duffy and Patricia Salber, MD, MBA, discuss the future of virtual visits, making decisions about when virtual visits are more appropriate than in-person visits, payment for virtual care, and more.
Listen above or through one of these podcast services:
iTunes: http://apple.co/2eYWTss
TuneIn: http://bit.ly/2gv7iwj
Stitcher: http://bit.ly/2gCqtFg
LLMs Show Promise, but Challenges Remain in Improving Inefficient Clinical Trial Screening
July 31st 2025Large language models (LLMs) such as GPT-3.5 and GPT-4 may offer a solution to the costly and inefficient process of manual clinical trial screening, which is often hindered by the inability of structured electronic health record data to capture all necessary criteria.
Read More